AU2003248566A1 - Novel anti-infectives - Google Patents

Novel anti-infectives

Info

Publication number
AU2003248566A1
AU2003248566A1 AU2003248566A AU2003248566A AU2003248566A1 AU 2003248566 A1 AU2003248566 A1 AU 2003248566A1 AU 2003248566 A AU2003248566 A AU 2003248566A AU 2003248566 A AU2003248566 A AU 2003248566A AU 2003248566 A1 AU2003248566 A1 AU 2003248566A1
Authority
AU
Australia
Prior art keywords
infectives
novel anti
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003248566A
Inventor
Kevin J. Duffy
Karen A. Evans
Duke M. Fitch
Adam T. Gates
Victor K. Johnston
Robert T. Sarisky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2003248566A1 publication Critical patent/AU2003248566A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • C12Q1/707Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003248566A 2002-05-24 2003-05-23 Novel anti-infectives Abandoned AU2003248566A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38295402P 2002-05-24 2002-05-24
US60/382,954 2002-05-24
PCT/US2003/016374 WO2003099801A1 (en) 2002-05-24 2003-05-23 Novel anti-infectives

Publications (1)

Publication Number Publication Date
AU2003248566A1 true AU2003248566A1 (en) 2003-12-12

Family

ID=29584481

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003248566A Abandoned AU2003248566A1 (en) 2002-05-24 2003-05-23 Novel anti-infectives

Country Status (2)

Country Link
AU (1) AU2003248566A1 (en)
WO (1) WO2003099801A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7582770B2 (en) 2004-02-20 2009-09-01 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
WO2006021340A1 (en) * 2004-08-23 2006-03-02 F.Hoffmann-La Roche Ag Heterocyclic antiviral compounds
ES2539969T3 (en) 2004-08-25 2015-07-07 Essentialis, Inc. Pharmaceutical formulations of ATP potassium channel activators and uses thereof
ES2314749T3 (en) 2004-12-21 2009-03-16 F. Hoffmann-La Roche Ag DERIVATIVES OF TETRALINA AND INDANO AND USES OF THE SAME AS 5-HT ANTAGONISTS.
KR20070116682A (en) * 2005-05-04 2007-12-10 에프. 호프만-라 로슈 아게 Heterocyclic antiviral compounds
ES2359735T3 (en) 2005-11-03 2011-05-26 F. Hoffmann-La Roche Ag ARYLSULPHONYL CHROMANES AS 5-HT6 INHIBITORS.
ATE529113T1 (en) 2006-01-05 2011-11-15 Essentialis Inc SALTS OF POTASSIUM ATP CHANNEL OPENER AND THEIR USES
JP2009526808A (en) 2006-02-17 2009-07-23 エフ.ホフマン−ラ ロシュ アーゲー Antiviral heterocyclic compounds
BRPI0713742A2 (en) 2006-06-20 2013-02-13 Hoffmann La Roche arylsulfonyl naphthalene derivatives and uses of these
AU2007263084A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
CN101472883A (en) 2006-06-20 2009-07-01 弗·哈夫曼-拉罗切有限公司 Arylsulfonamidyl tetralin derivatives and uses thereof
AP2009004812A0 (en) 2006-10-10 2009-04-30 Medivir Ab HCV nucleoside inhibitor
US20090060866A1 (en) * 2007-08-31 2009-03-05 Idenix Pharmaceuticals, Inc. Phosphadiazine hcv polymerase inhibitors i and ii
KR20110122874A (en) 2009-03-06 2011-11-11 에프. 호프만-라 로슈 아게 Heterocyclic antiviral compounds
MX2011011112A (en) 2009-04-25 2011-11-18 Hoffmann La Roche Heterocyclic antiviral compounds.
TW201103545A (en) 2009-06-24 2011-02-01 Hoffmann La Roche Heterocyclic antiviral compound
EP2480533A1 (en) 2009-09-21 2012-08-01 F. Hoffmann-La Roche AG Heterocyclic antiviral compounds
BR112012011221A2 (en) 2009-11-14 2016-04-05 Hoffmann La Roche biomarkers to predict rapid response to hcv treatment
CA2778206A1 (en) 2009-11-21 2011-05-26 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
EP2507636A1 (en) 2009-12-02 2012-10-10 F. Hoffmann-La Roche AG Biomarkers for predicting sustained response to hcv treatment
RU2534613C2 (en) 2013-03-22 2014-11-27 Александр Васильевич Иващенко Alkyl2-{[(2r,3s,5r)-5-(4-amino-2-oxo-2h-pyrimidine-1-yl)- -hydroxy- tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-proptonates, nucleoside inhibitors of rna-polymerase hcv ns5b, methods for producing and using them

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244522B1 (en) * 1973-08-06 1977-09-02 Serdex

Also Published As

Publication number Publication date
WO2003099801A1 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
AU2002335152A1 (en) Robot-phone
AU2002365198A1 (en) Novel anti-infectives
AU2003248566A1 (en) Novel anti-infectives
AU2003297235A1 (en) Anti-infectives
AU2003300957A1 (en) Anti-infectives
AU2003300956A1 (en) Anti-infectives
AU2002367810A1 (en) Bis-transition-metal-chelate-probes
AU2002368348A1 (en) Electrosomatogram
AU2002318053A1 (en) Suplier
AU2002341221A1 (en) Honey-brandy
AU2002348964A1 (en) Snowbike
AU2002344387A1 (en) Multifunction-pillow
AU2003240458A1 (en) 7-aminoimidazotriazones
AU2002100468A4 (en) Flexi-edger
AU2002100160A4 (en) Oxidirator
AU2002100541A4 (en) Backmate
AU2002100602A4 (en) Bonsystem
AU2002100655A4 (en) Armamulch
AU2002100739A4 (en) Neuramax
AU2002100747A4 (en) Powersell
AU2002100957A4 (en) Sluggit
AU2002100498A4 (en) Linline
AU2002100026A4 (en) Disc400
AU2002100482A4 (en) Tail-gate-ezy
AU2002100280A4 (en) Proshoe

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase